Functional and structural characterization of factor Xa dimer in solution

Biophys J. 2009 Feb;96(3):974-86. doi: 10.1016/j.bpj.2008.10.013.

Abstract

Previous studies showed that binding of water-soluble phosphatidylserine (C6PS) to bovine factor Xa (FXa) leads to Ca2+-dependent dimerization in solution. We report the effects of Ca2+, C6PS, and dimerization on the activity and structure of human and bovine FXa. Both human and bovine dimers are 10(6)- to 10(7)-fold less active toward prothrombin than the monomer, with the decrease being attributed mainly to a substantial decrease in k(cat). Dimerization appears not to block the active site, since amidolytic activity toward a synthetic substrate is largely unaffected. Circular dichroism reveals a substantial change in tertiary or quaternary structure with a concomitant decrease in alpha-helix upon dimerization. Mass spectrometry identifies a lysine (K(270)) in the catalytic domain that appears to be buried at the dimer interface and is part of a synthetic peptide sequence reported to interfere with factor Va (FVa) binding. C6PS binding exposes K(351) (part of a reported FVa binding region), K(242) (adjacent to the catalytic triad), and K(420) (part of a substrate exosite). We interpret our results to mean that C6PS-induced dimerization produces substantial conformational changes or domain rearrangements such that structural data on PS-activated FXa is required to understand the structure of the FXa dimer or the FXa-FVa complex.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Acetylation
  • Animals
  • Blood Coagulation
  • Calcium / pharmacology
  • Catalytic Domain
  • Cattle
  • Circular Dichroism
  • Dose-Response Relationship, Drug
  • Factor Xa / chemistry*
  • Factor Xa / metabolism*
  • Factor Xa Inhibitors
  • Humans
  • Lysine / metabolism
  • Models, Molecular
  • Oligopeptides / metabolism
  • Phosphatidylserines / chemistry
  • Phosphatidylserines / pharmacology
  • Protein Conformation / drug effects
  • Protein Multimerization* / drug effects
  • Prothrombin / metabolism
  • Solubility
  • Solutions
  • Spectrometry, Mass, Electrospray Ionization
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Factor Xa Inhibitors
  • Oligopeptides
  • Phosphatidylserines
  • Solutions
  • Prothrombin
  • Factor Xa
  • Lysine
  • Calcium